We are live on ! Find out more
FG

Foresight Group Portfolio holdings

AUM $556M
1-Year Est. Return 8.6%
This Fund
S&P 500
This Quarter Est. Return
+6.51%
1 Year Est. Return
+8.6%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$705M
AUM Growth
-$4.53M
Cap. Flow
-$41.6M
Cap. Flow %
-5.91%
Top 10 Hldgs %
41.43%
Holding
64
New
2
Increased
7
Reduced
40
Closed
4

Top Buys

Rank Stock Value
1
NVO
Novo Nordisk
NVO
+$8.5M
2
LNTH icon
Lantheus
LNTH
+$6.02M
3
VTR icon
Ventas
VTR
+$2.97M
4
EQIX icon
Equinix
EQIX
+$1.75M
5
CCI icon
Crown Castle
CCI
+$930K

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$7.07M
2
AMT icon
American Tower
AMT
+$5.73M
3
TEL icon
TE Connectivity
TEL
+$5.4M
4
ECL icon
Ecolab
ECL
+$4.12M
5
A icon
Agilent Technologies
A
+$4.03M

Sector Composition

Rank Sector Weight
1 Healthcare 22.03%
2 Technology 21.71%
3 Real Estate 18.35%
4 Industrials 18.28%
5 Materials 7.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ADSK icon
1
Autodesk
ADSK
$49.5B
$33.1M 4.7%
107,059
-9,094
-8% -$2.58M
TEL icon
2
TE Connectivity
TEL
$59.6B
$32.2M 4.56%
190,720
-35,596
-16% -$5.4M
TRMB icon
3
Trimble
TRMB
$13.2B
$31.7M 4.5%
417,653
-44,468
-10% -$2.99M
XYL icon
4
Xylem
XYL
$27.3B
$30.9M 4.39%
239,008
-31,143
-12% -$3.77M
ECL icon
5
Ecolab
ECL
$78.1B
$30.6M 4.34%
113,500
-16,218
-13% -$4.12M
MSA icon
6
Mine Safety
MSA
$7.35B
$29.1M 4.13%
173,884
-11,286
-6% -$1.77M
STE icon
7
Steris
STE
$22.3B
$27.2M 3.85%
113,103
-1,425
-1% -$332K
AZN icon
8
AstraZeneca
AZN
$263B
$27.2M 3.85%
97,946
-10,966
-10% -$1.54M
AMT icon
9
American Tower
AMT
$80.8B
$25.3M 3.59%
115,854
-26,528
-19% -$5.73M
LIN icon
10
Linde
LIN
$221B
$24.8M 3.51%
52,768
-15,492
-23% -$7.07M
SW
11
Smurfit Westrock
SW
$24.1B
$24.6M 3.49%
570,768
-6,862
-1% -$294K
A icon
12
Agilent Technologies
A
$39.1B
$23.4M 3.32%
198,192
-36,323
-15% -$4.03M
TMO icon
13
Thermo Fisher Scientific
TMO
$213B
$21.2M 3.01%
52,393
-6,104
-10% -$2.55M
DLR icon
14
Digital Realty Trust
DLR
$69.7B
$21M 2.98%
122,284
-13,852
-10% -$2.27M
DOC icon
15
Healthpeak Properties
DOC
$15.1B
$20M 2.83%
1,148,937
+18,215
+2% +$324K
EQIX icon
16
Equinix
EQIX
$101B
$18.7M 2.65%
23,761
+2,060
+9% +$1.75M
AWK icon
17
American Water Works
AWK
$26.7B
$16.5M 2.35%
118,835
-7,685
-6% -$1.1M
SLAB icon
18
Silicon Laboratories
SLAB
$7.17B
$16.2M 2.3%
110,142
-10,319
-9% -$1.22M
NXT icon
19
Nextpower Inc
NXT
$13.6B
$15.4M 2.19%
283,852
-15,721
-5% -$789K
LOPE icon
20
Grand Canyon Education
LOPE
$3.79B
$14.3M 2.02%
75,515
-7,759
-9% -$1.44M
VLTO icon
21
Veralto
VLTO
$23B
$14.2M 2.01%
140,501
-4,828
-3% -$466K
WMS icon
22
Advanced Drainage Systems
WMS
$10.6B
$13.1M 1.86%
114,329
-1,293
-1% -$145K
TT icon
23
Trane Technologies
TT
$100B
$12.8M 1.82%
29,372
-476
-2% -$188K
POWI icon
24
Power Integrations
POWI
$3.38B
$12.3M 1.75%
220,817
-2,381
-1% -$122K
ATS icon
25
ATS Corp
ATS
$2.64B
$12.2M 1.72%
381,812
-4,482
-1% -$123K

Similar funds

Foresight Group's Q2 2025 Portfolio in Review

As of Q2 2025, Foresight Group held 64 positions worth $705M, down 0.64% from $709M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Foresight Group withdrew a net $41.6M in Q2 2025, closing 4 positions and reducing 40 holdings. Its most notable exit was Cheniere Energy, an estimated $2.59M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, up from 22% a quarter earlier, followed by Technology and Real Estate.

Against the trend, Foresight Group opened a new position in Novo Nordisk worth $8.64M.

  • Foresight Group's largest Q2 2025 buy was Novo Nordisk: 124,919 shares worth $8.64M.
  • Foresight Group added most to Ventas in Q2 2025, an estimated $2.97M increase.
  • Foresight Group's biggest Q2 2025 reduction was Linde, cutting an estimated $7.07M.
  • Foresight Group fully exited Cheniere Energy in Q2 2025, selling an estimated $2.59M.
  • Foresight Group's ten largest holdings make up 41% of its $705M portfolio in Q2 2025.
  • Foresight Group opened 2 new positions and closed 4 in Q2 2025.
  • Foresight Group's portfolio value fell 0.64% quarter-over-quarter to $705M.

Based on Foresight Group's 13F filing for Q2 2025, filed 13 Aug 2025.